Explore every episode of the podcast Research Renaissance: Exploring the Future of Brain Science
| Title | Pub. Date | Duration | |
|---|---|---|---|
| How MicroRNAs Could Change Early Detection of Alzheimer’s Disease | 01 Apr 2026 | 00:51:14 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with neuroscientist Micaelly Alves, PhD candidate at Temple University and a 2025 Toffler Scholar supported by the Karen Toffler Charitable Trust. Micaelly shares her personal journey into neuroscience, inspired by watching her grandmother’s battle with Alzheimer’s disease, and dives into groundbreaking research on microRNAs, tiny molecules that may hold the key to earlier diagnosis and more personalized treatment for Alzheimer’s and cerebral amyloid angiopathy. The conversation explores how brain research is evolving, why personalized medicine matters, and how emerging technologies like RNA sequencing and bioinformatics are accelerating discovery.
• How microRNAs regulate brain pathways linked to Alzheimer’s disease
• Temple University Neuroscience Program
If you found this episode helpful: ✅ Subscribe on Apple Podcasts or Spotify To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| From Neuroscience to State Policy: How Science Shapes Decisions in California | 25 Mar 2026 | 00:56:52 | |
How does neuroscience shape state policy? And what happens when scientists step inside government?
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Unlocking Sex-Based Differences in Alzheimer’s Risk with Dr. Rachel Buckley | 15 Jul 2025 | 00:48:10 | |
In this powerful episode of Research Renaissance, host Deborah Westphal sits down with Dr. Rachel Buckley, Associate Professor of Neurology at Massachusetts General Hospital and Harvard Medical School. Together, they explore a growing body of research that challenges long-standing assumptions about sex differences in Alzheimer's disease. Dr. Buckley shares her unexpected journey from skepticism to advocacy in studying how biological sex and hormonal changes—particularly around menopause—can influence Alzheimer's risk, pathology, and progression. From PET scans to postmortem tissue studies, she unpacks what we now know about tau pathology in women, the role of hormone therapy, and how reproductive history may shape brain health. You’ll also hear about:
Whether you’re a caregiver, clinician, researcher, or simply curious about how brain health intersects with gender, this episode offers eye-opening insight and hope for the future. Guest Bio: Resources & Links: Subscribe & Follow: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| How Regenerative Biology Could Help Treat Alzheimer’s with Dr. Prabesh Bhattarai | 08 Jul 2025 | 00:45:23 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Prabesh Bhattarai, Associate Research Scientist - The Taub Institute for Research on Alzheimer's Disease, the aging Brain, Columbia University Irving Medical Center and a 2024 Toffler Scholar. Dr. Bhattarai shares his groundbreaking work on regenerative biology and how understanding the remarkable ability of certain fish to regrow neurons could eventually lead to new treatments for neurodegenerative diseases like Alzheimer’s. They explore: 🧠 How the fish geography can regenerate neurons lost to Alzheimer-like damage Dr. Bhattarai also discusses his latest findings around fibronectin 1 as a promising therapeutic target, and the complex but hopeful road ahead in Alzheimer’s research. 👉 If you’d like to learn more about Dr. Bhattarai’s work or connect with him, you can reach him at: pb2886@cumc.columbia.edu 🎧 Stay tuned for more episodes of Research Renaissance—exploring the future of brain science. Visit tofflertrust.org to subscribe and learn more about the Karen Toffler Charitable Trust and its mission to advance cutting-edge brain research. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Decoding Alzheimer’s: Breakthroughs in Neural Recording using and Biostatistics & Machine Learning | 01 Jul 2025 | 00:49:57 | |
In this exciting episode of Research Renaissance, host Deborah Westphal speaks with Dr. Ted Zwang, Assistant Professor of neurology at Massachusetts General Hospital and Harvard Medical School, Dr. Andrew Holbrook, Assistant Professor at UCLA and Jasen Zhang, PhD student in biostatistics in Holbrook’s lab. Together, they share how novel neural recording devices and advanced machine learning techniques are transforming the study of Alzheimer’s disease. Dr. Ted and Jasen discuss their collaborative project—funded by the Kavli Foundation, Cure Alzheimer’s Fund, and the Karen Toffler Charitable Trust—which captures how neurons change over time in Alzheimer’s mouse models. They reveal surprising discoveries about how some neurons “go quiet” and later recover—challenging long-held assumptions about neurodegeneration. The conversation also explores how these insights could lead to earlier diagnostics, predictive models of cognitive decline, and more personalized treatments for patients. 🔬 Topics include: Whether you’re a researcher, student, clinician, or curious learner, this episode offers a glimpse into the future of Alzheimer’s research—and why there’s new reason for hope. 🧠 Guests: Dr. Ted Zwang https://zwanglab.com/, Dr. Andrew Holbrook https://andrewjholbrook.github.io/ and Jasen Zhang https://www.linkedin.com/in/jasen-zhang/ To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| How Childhood Stress Shapes the Brain with Dr. Heather Brenhouse | 24 Jun 2025 | 00:53:39 | |
In this fascinating episode of Research Renaissance, host Deborah Westphal sits down with Dr. Heather Brenhouse, professor of psychology and director of the Developmental Neuropsychobiology Lab at Northeastern University—and a 2024 Toffler Scholar. Together, they explore the deep connections between childhood adversity, brain development, and long-term mental health. Dr. Brenhouse discusses why early life stress impacts some individuals more than others, how adversity can alter the timing of puberty, and why understanding neurodevelopment is essential to preventing psychiatric disorders. They also delve into the biology of behavior, the role of immune cells in the brain, and how evolving tools in neuroscience are helping uncover hidden patterns that shape health outcomes later in life. 🔬 Topics include:
Whether you're a researcher, student, or curious lifelong learner, this episode sheds light on how early experiences shape us—and what that means for preventing disease and promoting wellness across a lifetime. 🧠 Guest: Dr. Heather Brenhouse 🌐 For more episodes and updates, visit: tofflertrust.org To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Engineering the Brain—In the Lab and in Space | 17 Jun 2025 | 00:40:56 | |
In this fascinating episode of Research Renaissance, host Deborah Westphall welcomes Dr. Alysson Muotri, a professor in the Departments of Pediatrics and Cellular & Molecular Medicine at the University of California, San Diego., for a deep dive into what makes the human brain unique—and how understanding that uniqueness might unlock new treatments for neurological disorders. From stem cell brain models grown in the lab to sending "mini-brains" into space, Dr. Muotri shares his bold, unconventional path to advancing neuroscience and personalized medicine. Dr. Muotri discusses his work creating 3D brain organoids to model human neurological development, including conditions like autism and epilepsy. He explains how modern humans evolved slower brain development than our ancestors, and how that developmental window leaves us vulnerable to mutation and disease—but also offers the complexity that makes human cognition and collaboration possible. The conversation also touches on ethical frontiers, including the potential for lab-grown brains to develop consciousness, the future of neuroscience in space, and how traditional Amazonian medicine may offer clues to protecting the brain. In This Episode:
Quotes to Remember: Links & Resources:
Connect with Us: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Microscopic Conversations: How Organelles Communicate and What It Means for Curing Neurological Disease | 10 Jun 2025 | 00:45:39 | |
In this episode of Research Renaissance, host Deborah Westphal welcomes Dr. Yvette Wong, Assistant Professor of Neurology at Northwestern University and 2024 Toffler Scholar, for a deep dive into the dynamic inner world of cells—and how her lab is uncovering new clues about neurodegenerative diseases by studying the microscopic interactions between organelles. Dr. Wong discusses how organelles like mitochondria and lysosomes don’t just function in isolation—they actually “talk” to each other at contact points within cells. These cellular conversations may hold the key to unlocking better understanding and treatments for conditions like ALS, Parkinson’s, and Huntington’s disease. Through vivid analogies (like buses exchanging cargo), Dr. Wong helps translate complex science into clear visuals, while also highlighting how advances in super-resolution live-cell microscopy and data analysis are transforming what’s possible in neuroscience. 🔬 Topics Covered:
🔗 Resources & Links:
🎧 Subscribe & Follow: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Aging with Dignity: Advancing Equity, Access, and Brain Health | 03 Jun 2025 | 00:53:44 | |
In this compelling episode of Research Renaissance, host Deborah Westphal sits down with Sue Peschin, President and CEO of the Alliance for Aging Research, for a candid conversation about the intersection of science, policy, and aging. From Alzheimer’s drug coverage to the future of stem cell research, they unpack what it truly means to age with dignity—and how equity, access, and advocacy play a critical role. Sue shares her personal journey into aging research, her leadership transition at the Alliance, and the organization’s long-standing commitment to ensuring older adults receive fair and effective healthcare. They explore the challenges of Coverage with Evidence Development (CED) in Medicare, the rising need for culturally competent communication, and how the stigma around neuropsychiatric symptoms in aging can be addressed through education and empathy. Key Topics Covered:
Memorable Quote: Resources & Links: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Rewiring Brain Research—Why Networks Matter as Much as Genes | 27 May 2025 | 00:54:16 | |
In this eye-opening episode of Research Renaissance, Dr. Rod Scott takes us on a journey through the emerging science of brain networks, complex adaptive systems, and why rethinking how we treat neurological conditions like epilepsy and autism might be the key to improving outcomes—especially in children. Dr. Scott explains why he views the brain not as a collection of isolated parts, but as a dynamic, self-organizing system. From his clinical experience to his cutting-edge lab work on neural firing patterns and cognitive behavior, he shares why focusing on repairing brain networks—rather than treating individual genes or symptoms—could reshape our entire approach to neurological care. Key highlights include:
Whether you're a clinician, researcher, or simply curious about the future of neuroscience, this episode offers a radically different perspective on what it means to heal the brain. Resources & Links:
Connect with Us: 💌 Subscribe to the show for more thought-provoking interviews To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Inside the Mind of Brain Cancer: Modeling Glioblastoma with Dr. Frank Furnari | 20 May 2025 | 00:54:49 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Frank Furnari, professor of medicine at UC San Diego and co-director of the Brain Tumor Program at the Sanford Stem Cell Institute. Together, they explore one of the most aggressive and complex cancers known to medicine—glioblastoma—and the innovative tools his team is developing to study and treat it. 🔬 Topics Covered:
💡 Dr. Furnari also reflects on his career beginnings, his leadership philosophy, and what excites him most about the future of brain cancer research. 🔗 Connect with Dr. Frank Furnari:
🧠 May is Brain Tumor Awareness Month To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Inside the Neurodegeneration Puzzle: A Conversation with Jackson Mace | 13 May 2025 | 00:52:02 | |
In this compelling episode of Research Renaissance, host Deborah Westphal sits down with Jackson Mace, a neuroscience PhD candidate at Johns Hopkins University and 2023 Toffler Scholar, to explore the cutting-edge research driving our understanding of neurodegenerative diseases—particularly multiple sclerosis (MS). Drawing from personal experience—his father’s MS diagnosis—and a deep academic curiosity, Jackson shares the winding path that led him from undergraduate lab work to a promising career in neuroimmunology. Together, they discuss: 🧠 Why MS is more than just an autoimmune condition—and how it’s being reframed as a neurodegenerative disease Whether you're a fellow researcher, a curious patient advocate, or simply fascinated by the future of brain science, this episode sheds light on the personal and professional forces driving the next generation of neuroscience discovery. 👤 Guest: 🔗 Learn more about the show and the Karen Toffler Charitable Trust: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Vagus Nerve Revolution: How Bioelectronic Medicine Is Changing the Future of Healthcare | 18 Mar 2026 | 01:04:13 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Şiyar Bahadır, neurosurgeon and Elmezzi Scholar at the Feinstein Institute for Medical Research, to explore the cutting edge of neuroscience, bioelectronic medicine, and the powerful role of the vagus nerve in regulating nearly every organ system in the body. Dr. Bahadır shares his journey from the operating room to advanced research, explains how mapping the brain and nervous system is revolutionizing patient outcomes, and dives into groundbreaking therapies using electrical stimulation to treat inflammatory diseases like rheumatoid arthritis. The conversation also uncovers how the brain reorganizes itself after trauma, the future of precision neurosurgery, and why the vagus nerve may hold the key to an entirely new form of medicine.
Dr. Şiyar Bahadır 📧 Email: sbahadir@northwell.edu
If you enjoyed this episode, please: ✅ Subscribe to Research Renaissance Your support helps us bring more groundbreaking research conversations to you! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring the Role of Astrocytes and APOE in Alzheimer's Disease with Dr. Alberto Serrano-Pozo | 06 May 2025 | 00:42:41 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Alberto Serrano-Pozo, Assistant Professor of Neurology at Harvard Medical School, staff neurologist at Massachusetts General Hospital, and a 2022 Toffler Scholar. Together, they explore Dr. Serrano-Pozo’s pioneering research into the role of glial cells—specifically astrocytes—and the APOE gene in the development and progression of Alzheimer’s disease. Dr. Serrano-Pozo discusses how astrocytes, long overlooked in favor of neurons, are now recognized as key players in maintaining brain health—and how their dysfunction may contribute to Alzheimer's pathology. The conversation also covers the complexities of the APOE gene variants, how recent discoveries are reshaping our understanding of Alzheimer's across different populations, and promising advances in gene-editing research. Dr. Serrano-Pozo also reflects on the dual role he plays as both a researcher and a clinician, how patient interactions inspire his lab work, and why cautious optimism is warranted as new therapies and technologies emerge. What You'll Learn:
Key Quotes:
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Rewiring the Brain: Non-Invasive Neurotech & the Future of Treatment with Ana Maiques | 29 Apr 2025 | 00:48:13 | |
In this illuminating episode of Research Renaissance, host Deborah Westphal sits down with Ana Maiques, CEO and co-founder of Neuroelectrics, a groundbreaking company at the forefront of non-invasive brain stimulation technology. Together, they explore the intersection of neuroscience, entrepreneurship, and innovation, diving deep into how electrical brain stimulation is changing the future of treatment for neurological disorders like epilepsy, depression, and Alzheimer’s. Ana shares her unconventional journey into entrepreneurship, her commitment to ethical tech, and the long road to FDA approval. She also discusses the development of Neuroelectrics’ personalized brain therapies and the potential for at-home use of medical-grade neurostimulation devices.
Connect with Ana Maiques: Follow Research Renaissance: To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| How Philanthropy is Accelerating Alzheimer’s Breakthroughs with Meg Smith | 22 Apr 2025 | 00:55:15 | |
In this episode of Research Renaissance, host Deborah Westphal is joined by Meg Smith, the Chief Executive Officer of Cure Alzheimer’s Fund. They dive deep into the innovative and high-impact research Cure Alzheimer’s Fund is supporting to prevent, slow, and ultimately cure Alzheimer’s disease. Meg shares her fascinating career journey from law and consulting to leading an organization that is revolutionizing brain disease research. Together, they discuss:
🔗 Learn more about Cure Alzheimer’s Fund: www.curealz.org 🎧 Listen & Subscribe: 🔔 Don’t forget to rate and review! If you enjoyed this episode, share it with your network and help us spread the word about advancing brain science. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Oxygen and Alzheimer’s: Dr. Nancy Ruiz on the Vascular Connection | 15 Apr 2025 | 00:41:02 | |
Can oxygen levels in the brain help explain Alzheimer’s disease? In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Nancy E. Ruiz, a Harvard Medical School research fellow and 2023 Toffler Scholar, to explore a powerful yet underexamined piece of the Alzheimer’s puzzle: vascular dysfunction. Dr. Ruiz shares how her background in physics and biology led her to cutting-edge brain research using advanced imaging tools like two-photon phosphorescence lifetime imaging. Together, they dive into how oxygenation, blood flow, and lifestyle factors such as exercise and diet may hold the key to prevention — and why we must look beyond amyloid and tau to fully understand the disease. Plus, hear Dr. Ruiz’s insights on the importance of interdisciplinary collaboration, working with human brain tissue, and how she balances scientific rigor with pottery, running, and a good meal. 📌 Don’t forget to follow and rate the show! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Innovation in Biotech & Leadership with Catharine Smith | 08 Apr 2025 | 00:55:20 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Catharine Smith, Executive Director of the Termeer Foundation, to explore innovation in the biotech industry and the evolving role of leadership. They dive into how biotech leaders are shaping the future of healthcare, supporting emerging companies, and addressing rare diseases. Key Topics Covered
🗣️ "If we look at rare diseases as a collective, they’re not rare at all. The unmet need is massive, and we’re seeing patient advocates leading the way in finding solutions." – Catharine Smith
📌 Follow Research Renaissance: Website | LinkedIn 💡 Enjoyed the episode? Subscribe, leave a review, and share it with colleagues interested in biotech innovation and leadership! 🔍 Want to learn more or collaborate? Contact Karen Toffler Charitable Trust via our website or LinkedIn 🎧 Listen & Subscribe: Available on Spotify, Apple Podcasts, and other major platforms. Until next time—onward and upward! 🚀 To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring the Future of Science Policy with Dr. Carrie Wolinetz | 02 Apr 2025 | 00:59:43 | |
In this episode of Research Renaissance, host Deborah Westphal welcomes Dr. Carrie Wolinetz, a leading science and health policy expert. With an extensive background, including roles at the National Institutes of Health (NIH) and the White House Office of Science and Technology Policy, Dr. Wolinetz shares her insights on the evolving landscape of medical research funding, the role of science policy, and the critical intersection between government, private sector, and research institutions. From the historical foundations of federally funded science to the challenges posed by shifting political landscapes, Dr. Wolinetz offers a compelling perspective on the future of research and public health.
🔬 The Role of Science Policy: How policy shapes the research ecosystem and why it’s essential for medical advancements.
💭 “Science is all about solving problems. The best research happens when patients, researchers, and policymakers work together.” 💭 “The Human Genome Project had a 141-to-1 return on investment—nearly a trillion dollars in impact.” 💭 “Science isn’t just about discovery; it’s about making sure discoveries lead to real-world impact.” 💭 “We need a new national vision for public health—one that integrates the lessons of COVID-19 and prioritizes rapid response to emerging threats.”
📌 Karen Toffler Charitable Trust: tofflertrust.org
📢 Subscribe for More Episodes! Stay informed on groundbreaking research and policy discussions shaping the future of science. 🎧 Listen & Subscribe on Your Favorite Platform 🚀 Until next time—onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Revolutionizing ALS Drug Development with Dr. Kasper Roet | 25 Mar 2025 | 00:46:48 | |
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal sits down with Dr. Kasper Roet, CEO and co-founder of QurAlis, to explore the evolution of ALS drug development, the power of genetic insights, and the future of personalized medicine for neurodegenerative diseases.
✔️ From Spinal Cord Injury to ALS – Dr. Roet’s journey from spinal cord injury research to ALS, and how genetic discoveries reshaped his focus.
🔹 ALS is no longer a “mystery disease” – recent genetic breakthroughs are leading to targeted treatments.
Stay ahead in the world of cutting-edge neuroscience and biotech breakthroughs. Subscribe to Research Renaissance on your favorite podcast platform and visit TofflerTrust.org for more insights. 🔗 Want to collaborate or learn more? Connect with Dr. Kasper Roet and his team at Quralis or email info@quralis.com. 🚀 Join us in advancing the future of brain research—because patients can’t wait! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Future of Research & Development with Dr. Melissa Flagg | 18 Mar 2025 | 01:05:39 | |
In this thought-provoking episode of Research Renaissance, host Deborah Westphal welcomes Dr. Melissa Flagg, an advisor for the Andrew W. Marshall Foundation and a research fellow at the Acquisition Innovation Research Center. Dr. Flagg has had an extensive career spanning government, academia, and the private sector, including her role as Deputy Assistant Secretary of Defense for Research. Together, they explore the evolving landscape of research and development (R&D) in the U.S. and beyond. They discuss the history, funding models, and gaps in the system, as well as new opportunities to connect scientific research with real-world applications. Dr. Flagg also offers a candid perspective on how research institutions prioritize funding, the challenges faced by early-career researchers, and the growing influence of industry and philanthropy in driving scientific innovation. 💡 Key Topics Discussed: 📢 Memorable Quotes from Dr. Melissa Flagg: 🎧 Tune in to hear a powerful conversation on the past, present, and future of research! 🔗 Connect with Dr. Melissa Flagg:
📍 Learn More: 💡 Join the Conversation: 🎙️ Listen Now! 🚀 To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Reversing Cognitive Decline: The Power of Lifestyle Medicine with Dr. Dean Ornish | 11 Mar 2025 | 00:35:35 | |
In this enlightening episode of Research Renaissance, host Deborah Westphal sits down with Dr. Dean Ornish, founder of the Preventative Medicine Research Institute and a pioneer in lifestyle medicine. Dr. Ornish shares groundbreaking research on how lifestyle changes—including diet, exercise, stress management, and social connection—can not only prevent but even reverse chronic diseases, including early-stage Alzheimer’s disease. With nearly five decades of research, Dr. Ornish discusses how a whole-food, plant-based diet, moderate exercise, mindfulness practices, and social support can lead to remarkable improvements in cognition, heart disease, cancer, and even gene expression. This episode dives deep into the science behind these findings, the pushback from traditional medicine, and the potential for insurance coverage of preventive healthcare. Join us for a conversation that challenges conventional medical thinking and offers hope and empowerment for those at risk of cognitive decline and other chronic conditions.
✔️ What is Lifestyle Medicine? – How simple lifestyle changes can be more effective than high-tech, expensive treatments.
🗣️ "It’s not about fear of dying—it’s about the joy of living." – Dr. Dean Ornish
🔗 Learn more about Dr. Ornish’s work: Ornish.com 📢 Stay Connected:
🎧 Listen Now & Discover How Lifestyle Medicine is Changing the Future of Health! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Future of Alzheimer's Treatment: Philanthropy, Innovation, and Hope with Katie Pizzone | 04 Mar 2025 | 00:44:52 | |
In this episode of Research Renaissance, host Deborah Westphal speaks with Katie Pizzone, Senior Director of Philanthropy at the Alzheimer’s Drug Discovery Foundation (ADDF). They discuss the critical role of philanthropy in advancing Alzheimer's research, the groundbreaking venture philanthropy model that ADDF employs, and the innovative treatments and diagnostics shaping the future of Alzheimer’s care. Katie shares her personal journey into philanthropy, her early experiences in healthcare fundraising, and how ADDF is working to accelerate translational science—bringing new diagnostics, treatments, and preventive solutions from research to real-world impact. Join us for a thought-provoking conversation about the intersection of philanthropy and science, the growing field of precision medicine, and how collaboration is key to curing Alzheimer’s.
✔️ The Power of Venture Philanthropy – How ADDF’s unique funding model bridges the gap between early research and real-world treatments.
🗣️ "100% of every donation goes directly to science, thanks to a transformative gift from the Lauder family." – Katie Pizzone
🔗 Learn more about Alzheimer’s Drug Discovery Foundation: ALZdiscovery.org 📢 Stay Connected: 🎧 Listen Now & Discover How Philanthropy is Driving Breakthroughs in Alzheimer’s Treatment! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Inside Health Informatics: Data, Decisions, and the Future of Patient Care | 11 Mar 2026 | 01:20:26 | |
Healthcare today runs on data, but few people understand how deeply information systems shape patient outcomes, clinician workflows, and long-term public health. In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Caterina (Cat) Lasome, a nationally recognized leader in health informatics and digital health transformation. Drawing from 23 years as an Army nurse and decades working across the Department of Defense, VA, NIH, and federal health systems, Cat explains how informatics sits at the intersection of clinical care, technology, and human behavior. Together, they explore what happens when data flows well, where systems still fracture, and why learning healthcare systems may be the key to safer, more adaptive medicine.
Dr. Caterina (Cat) Lasome is a nationally recognized expert in health informatics, clinical systems, and digital health transformation. A retired Army nurse with 23 years of service, she has worked across the Department of Defense, Veterans Affairs, NIH, and HHS, and is the President & CEO at iON Informatics, LLC. To contact Dr. Lasome cat@ioninformatics.com.
If you found this episode valuable:
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring Cognitive Super Aging and Brain Science with Dr. Tamar Gefen | 05 Nov 2024 | 00:53:41 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Tamar Gefen, an Associate Professor at the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University. Dr. Gefen, a 2023 Toffler Scholar, shares insights into her groundbreaking work on dementia syndromes and age-related cognitive disorders, including her fascinating research on cognitive "super agers." Key Discussion Points:
Key Quotes: "I feel like I’m among tiny gods lined up in a fridge... These organs were the source of life for every human that made that precious donation." – Dr. Tamar Gefen "Aging suffers from poor marketing, and we need to show that aging can be graceful and fun." – Dr. Tamar Geffen Thank you for joining us on this insightful journey into brain science. Be sure to subscribe to Research Renaissance for more conversations at the cutting edge of neurological research. Until next time, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Empowering Future Scientists: The SARE Program at Johns Hopkins University | 31 Oct 2024 | 00:52:35 | |
Guests:
Summary: Key Topics:
Memorable Quotes:
To learn more about the SARE program and how to support its mission, visit the Initiative for Careers in Science and Medicine (CSM) at Johns Hopkins here. For partnership opportunities or to contribute to the program, contact Dr. Doug Robinson at dnr@jhi.edu. Applications for the 2025 SARE program open on November 1st and close on February 1st. Visit the SARE program page for details on how to apply. Thank you for joining us on this episode of Research Renaissance. Stay tuned for more discussions with leading voices in brain science and the people shaping the future of research. Until next time—onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring the Future of Alzheimer's Research with Dr. Robert Vassar | 15 Oct 2024 | 00:57:26 | |
In this enlightening episode of Research Renaissance, Deborah Westphal speaks with Dr. Robert Vassar, a renowned neuroscientist and Director of the Mesulam Center for Cognitive Neurology and Alzheimer's Disease at Northwestern University. Dr. Vassar shares his personal journey into the field of Alzheimer’s research, the evolution of diagnostic tools, and the latest technological breakthroughs in the fight against neurodegenerative diseases. Key Topics Covered:
Memorable Quotes: "My purpose in life crystallized when my mother was diagnosed with Alzheimer's. I knew I had to study this disease to try to stop it." "The future of Alzheimer’s treatment will rely on prevention. We need to catch the disease before symptoms even begin." "Our study participants are the real heroes. Without their altruistic contributions, we couldn’t make any progress." Listeners interested in supporting Alzheimer’s research or participating in studies at Northwestern can visit the Mesulam Center for Cognitive Neurology and Alzheimer's Disease website for more information. The center welcomes volunteers for clinical trials and other research initiatives. For more updates on cutting-edge research in brain science, subscribe to Research Renaissance and visit the Karen Toffler Charitable Trust website at tofflertrust.org. Share your thoughts, suggestions, or inquiries by contacting us through the website. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Pioneering Drug Delivery for Neurological Diseases with Afreen Allam | 08 Oct 2024 | 00:46:30 | |
In this compelling episode of Research Renaissance, host Deborah Westphal sits down with Afreen Allam, the CEO and founder of SiNON Nano Sciences and a 2023 Termeer Fellow. Afreen shares her journey from aspiring medical student to biotech entrepreneur, discussing her groundbreaking work in drug delivery for neurological diseases. The conversation delves into the challenges and triumphs of developing a platform that can cross the blood-brain barrier, offering hope for the treatment of diseases like Cancer, Alzheimer's, Parkinson's, and brain tumors. Key Discussion Points:
Guest Bio: Afreen Allam is the CEO and founder of SiNON Nano Sciences, a biotech startup focused on developing a platform for targeted drug delivery to the brain. A 2023 Termeer Fellow, Afreen is passionate about improving patient outcomes and has a background in biochemistry, microbiology, and business. Call to Action: Subscribe to Research Renaissance for more episodes featuring trailblazers in brain science and healthcare innovation. Visit tofflertrust.org for additional resources and updates. Until then, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Unraveling the Senses: Dr. Douglas Storace on the Olfactory Bulb and Brain Function | 01 Oct 2024 | 01:00:59 | |
Welcome to the latest episode of Research Renaissance, presented by the Karen Toffler Charitable Trust. I’m your host, Deborah Westphal, and today, we have the pleasure of speaking with Dr. Douglas Storace, a neuroscientist and assistant professor at Florida State University. Dr. Storace is also a 2022 Toffler Scholar. Our discussion will delve into his research on the olfactory bulb, a crucial brain region responsible for processing smells, and its broader implications for understanding brain function and our bodies.
Thank you for joining us on this episode of Research Renaissance. For more information and to stay updated on our latest episodes, subscribe to the podcast and visit our website at tofflertrust.org. Feel free to contact us with your thoughts, suggestions, or to learn more about the Karen Toffler Charitable Trust. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Power of Strategic Communication in Healthcare with Anne Woodbury | 24 Sep 2024 | 00:54:51 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Anne Woodbury, the founder and CEO of Cura Strategies, a healthcare communication and public affairs agency. Together, they explore the crucial role of strategic communication in shaping healthcare policies and improving patient outcomes. Anne shares her journey from Capitol Hill to entrepreneurship, driven by a passion for transforming the healthcare system. Listeners will gain insights into how effective advocacy and communication strategies can drive change in healthcare, the importance of educating policymakers, and the growing awareness around mental health in the corporate world. Anne also discusses Cura Cares, her company's charitable arm, and its impact on both employees and the communities they serve. Key Discussion Points:
For more information about Cura Strategies and their work in healthcare communication and advocacy, visit CuraStrategies.com or AdvocacyAccelerator.us. You can also connect with Anne Woodbury on LinkedIn. Don't forget to subscribe to Research Renaissance for more insightful episodes exploring the forefront of brain science and healthcare innovation. Visit TofflerTrust.org for additional resources and updates. Until then, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Unraveling ALS and Genetic Modifiers with Dr. Zhe Zhang | 17 Sep 2024 | 00:46:55 | |
In this insightful episode of Research Renaissance, host Deborah Westphal engages in an enlightening conversation with Dr. Zhe Zhang, a research associate at Johns Hopkins and a 2021 Toffler Scholar. Dr. Zhang discusses her journey from aspiring to be a doctor to becoming a dedicated researcher focused on neurodegenerative diseases, particularly ALS. She shares her innovative work on establishing a platform to find genetic modifiers that can improve cell survival and slow the progression of ALS.
Join us in advancing our understanding of the brain and addressing its ailments. Until then, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Neurovascular Breakthroughs: Exploring Alzheimer's Treatments with Dr. Elisa Canepa | 10 Sep 2024 | 00:47:50 | |
In this enlightening episode of Research Renaissance, host Deborah Westphal engages in a compelling conversation with Dr. Elisa Canepa, a neurobiologist and associate scientist from Temple University and a 2022 Toffler Scholar. Dr. Canepa shares her journey into neuroscience, driven by a fascination with the brain's complexity and its pivotal role in shaping our identity and cognitive functions. They delve into Dr. Canepa’s cutting-edge research on cerebral vascular dysfunction, particularly focusing on the potential of carbonic anhydrase inhibitors (CAIs) in treating Alzheimer's disease.
Join us in advancing our understanding of the brain and addressing its ailments. Until then, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Neurovascular Dysfunction and Neuroinflammation in Alzheimer's with Ashley Carey | 27 Aug 2024 | 00:40:46 | |
In this episode of Research Renaissance, host Deborah Westphal engages in an enlightening conversation with Ashley Carey, a PhD candidate and 2023 Toffler Scholar at Temple University's Lewis Katz School of Medicine. Ashley's research focuses on the neurovascular dysfunction and neuroinflammation associated with Alzheimer's disease. She shares her journey from aspiring marine biologist to neuroscience researcher, highlighting the importance of cardiovascular health in preventing Alzheimer's.
Ashley Carey is a PhD candidate and graduate research assistant in Dr. Silvia Fossati’s lab at Temple University. She is also a 2023 Toffler Scholar. Her research examines the impact of cardiovascular risk factors on Alzheimer's disease, specifically focusing on neurovascular dysfunction and neuroinflammation. Ashley's work aims to understand how conditions like hyperhomocystinemia and hypertension contribute to Alzheimer's pathology.
Career Motivation and Journey:
Research Focus:
Significant Findings:
Challenges in Alzheimer's Research:
Interdisciplinary Collaborations:
Future Directions and Aspirations:
Mentoring and Funding:
Until then, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Innovative Collaborations in Biotech with Marissa Pettit Jones | 20 Aug 2024 | 00:50:24 | |
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal sits down with Marissa Pettit Jones, the Director of Business Development at Genentech and co-founder of Nucleate. They discuss Marissa's fascinating journey from biomedical engineering at Yale to her strategic role at Genentech, bridging the gap between science and business. Marissa shares insights into Genentech's innovative approaches, the dynamic pace of biotech advancements, and the critical role of Nucleate in fostering the next generation of biotech leaders. Marissa Pettit Jones is the Director of Business Development at Genentech, where she guides strategic business initiatives and partnerships. She is also the co-founder of Nucleate, a non-profit organization dedicated to empowering biotech entrepreneurs. Marissa's unique background in biomedical engineering and strategy consulting provides her with a valuable perspective on the intersection of science and business. Key Discussion Points: Introduction to Genentech: Genentech's role in developing treatments for various diseases. The company's structure as part of the Roche Group. Marissa's Career Path: From studying biomedical engineering at Yale to strategic consulting at Bain. Transition to business development in biotech and the founding of Nucleate. Nucleate's Mission and Impact: Overview of Nucleate as a student-run non-profit supporting biotech entrepreneurship. Success stories and significant achievements, including the creation of 78 companies and over $310 million raised. Challenges and Opportunities in Biotech: Bridging the gap between research and market-ready innovations. The importance of strategic partnerships and collaboration in advancing biotech solutions. Innovative Therapeutic Advancements: The evolution of CAR T therapies and their potential to transform cancer treatment. The role of machine learning and data in accelerating drug discovery and development. Ethical Considerations in Biotech: The importance of maintaining ethical standards, especially in data usage and patient privacy. Balancing rapid innovation with ethical responsibility. Future of Biotech: Exciting trends and potential breakthroughs in the next 5-10 years. The continuous evolution of biotech entrepreneurship and the importance of lifelong learning. Thank you for joining us on Research Renaissance. We appreciate Marissa's time and insights into the biotech industry's dynamic landscape. Keep exploring and advancing our understanding of the brain and its ailments. Until next time, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Why Alzheimer’s Is No Longer a Black Box: Science, Resilience, and the Path Forward | 04 Mar 2026 | 00:59:00 | |
For decades, Alzheimer’s disease was treated as an unavoidable consequence of aging. In this episode of Research Renaissance, Dr. Jessica Rexach explains why that framing is no longer true. Drawing on 20 years at the intersection of clinical neurology, genetics, and experimental neuroscience, Dr. Rexach walks us through a profound shift in the field. Today, scientists can model human brain circuits, measure Alzheimer’s pathology through blood-based biomarkers, and study why some brains remain cognitively resilient even with disease pathology present. The science, she argues, is ready. The real question is whether society will commit the resources needed to finish the job.
Guest Information Dr. Jessica Rexach 📧 Email: jrexach@mednet.ucla.edu Listen & Subscribe If you found this episode valuable:
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Technology Advancing Alzheimer's Research with Dr. Sudeshna Das | 13 Aug 2024 | 00:59:00 | |
In this episode of Research Renaissance, host Deborah Westphal dives into a fascinating conversation with Dr. Sudeshna Das, Associate Professor of Neurology at Mass General Hospital and Harvard Medical School. Dr. Das is a pioneer in the field of biomedical informatics and a 2022 Toffler Scholar. Her work focuses on developing tools for multi-scale data integration from molecular to clinical data and applying data science approaches to study neurodegenerative diseases, particularly Alzheimer’s disease.
Dr. Sudeshna Das is an Associate Professor of Neurology at Mass General Hospital and Harvard Medical School. She specializes in biomedical informatics and has a keen interest in developing tools for integrating diverse data sets, from molecular to clinical, to understand complex diseases like Alzheimer's. Dr. Das has a rich background in engineering and computational biology, making significant contributions to the field of drug discovery and neurodegenerative disease research.
Stay tuned for more episodes of Research Renaissance by subscribing to our podcast. For further information and updates, visit our website at TofflerTrust.org. We welcome your thoughts and suggestions, so feel free to reach out! Until then, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Future of Technology and Healthcare with Ian Kahn | 06 Aug 2024 | 00:51:31 | |
In this episode of Research Renaissance, hosted by Deborah Westphal, we explore the future of technology and its impact on healthcare with guest Ian Kahn, a theoretical futurist. Ian discusses his role as a theoretical futurist, the importance of future readiness for organizations, and the evolution of technology in healthcare. He also shares insights into his work, including his series "The Futurist" and his books on emerging technologies. Ian Kahn is a renowned theoretical futurist helping organizations achieve future readiness. He hosts the series "The Futurist" on Amazon Prime and has written extensively on technology topics such as AI, blockchain, and the metaverse. Ian's expertise lies in predicting and preparing for future technological advancements. Key Discussion Points: The Role of a Theoretical Futurist:
Future Readiness of Companies:
The Futurist Series:
Books on Emerging Technologies:
AI in Healthcare:
Ethics and Brain-Computer Interfaces:
Global Impact and Accessibility:
Privacy and Security in Healthcare:
For more information and to stay updated on future episodes, subscribe to Research Renaissance and visit the Karen Toffler Charitable Trust website at tofflertrust.org. Feel free to reach out with your thoughts and suggestions. Thank you for joining us on this insightful journey into the future of technology and healthcare. Until next time, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Navigating the Future of Alzheimer's Research with Dr. Bradley Hyman | 30 Jul 2024 | 00:53:27 | |
Welcome to Research Renaissance presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal engages in a thought-provoking conversation with Dr. Bradley Hyman, Director of the Alzheimer's Disease Research Unit at Massachusetts General Hospital and John P. Pinney Jr. Professor of Neurology at Harvard Medical School. Dr. Hyman shares his insights on the evolving understanding of Alzheimer's disease, the impact of technological advancements on research, and the importance of multidisciplinary collaboration in tackling this complex condition. Dr. Bradley Hyman is a leading figure in Alzheimer's disease research, serving as the Director of the Alzheimer's Disease Research Unit at Massachusetts General Hospital and holding the John P. Pinney Jr. Professorship of Neurology at Harvard Medical School. With decades of experience, Dr. Hyman has witnessed significant paradigm shifts in the field and continues to drive innovative research aimed at understanding and combating this devastating disease. Key Discussion Points:
Thank you for joining us on this episode of Research Renaissance. Stay tuned for more episodes as we continue to explore the forefront of brain science and its implications for our understanding and treatment of neurological diseases. Until next time, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring Neurovirology with Dr. Maria Nagel | 23 Jul 2024 | 01:01:35 | |
Welcome to Research Renaissance presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal dives into the fascinating world of neurovirology with Dr. Maria Nagel, a renowned professor, clinician, and scientist from the Department of Neurology at the University of Colorado. Dr. Nagel shares her insights on how viruses affect the nervous system, focusing on the varicella zoster virus (VZV) and its implications for diseases such as stroke and shingles. Dr. Maria Nagel is a distinguished neurovirologist specializing in the study of how viruses impact the brain, spinal cord, and peripheral nerves. With a particular focus on VZV, Dr. Nagel's work explores the virus's ability to remain latent and later reactivate, leading to various neurological diseases. Her research has significant implications for understanding and potentially preventing conditions like stroke and dementia. Key Discussion Points:
Thank you for joining us on this episode of Research Renaissance. We hope you found Dr. Maria Nagel's insights into neurovirology and the impact of viruses on the nervous system both enlightening and thought-provoking. Stay tuned for more episodes as we continue to explore the forefront of brain science and its implications for our understanding and treatment of neurological diseases. Until next time, onward and upward! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Unlocking the Mysteries of Sleep with Dr. Alon Avidan | 16 Jul 2024 | 01:14:22 | |
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. Embark on a journey into the forefront of cutting-edge brain science as we feature insightful discussions with a diverse array of guests, from early career researchers pioneering groundbreaking science to influential voices in investment communities, policymaking, and research institutions. Together, we delve into neurological diseases, their causes, treatments, and the quest for cures. In this episode, we are joined by Dr. Alon Avidan, a distinguished Professor of Neurology at UCLA and the Director of the UCLA Sleep Disorders Center. Dr. Avidan, also a 2020 Toffler Scholar, is an expert in sleep medicine and its intricate relationship with neurological diseases. Dr. Avidan shares his insights on how sleep impacts brain health and explores the bidirectional relationship between sleep disorders and conditions like Parkinson's and Alzheimer's diseases. He discusses the importance of early diagnosis and the potential for neuroprotective treatments. The discussion covers: - The importance of sleep in overall neurological health. - Differences between REM and non-REM sleep and their roles in brain health. - The connection between REM sleep behavior disorder (RBD) and Parkinson's disease. - Historical context and scientific milestones in understanding sleep behavior disorders. - Practical advice on improving sleep quality and recognizing sleep disorders. - Dr. Avidan’s upcoming textbook on sleep medicine and recommended readings for the general public. - The role of wearable technology in tracking and improving sleep. - Continuing education for clinicians and public awareness initiatives. Dr. Avidan’s groundbreaking research offers hope for early intervention and prevention of neurodegenerative diseases, emphasizing the critical role of sleep in maintaining optimal brain health. "Sleep is not a luxury; it's a necessity for maintaining optimal brain health." -Dr. Alon Avidan Thank you for joining us on this episode of Research Renaissance. Until next time, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Developing AI Tools for Dementia Screening with Dr. Vijaya Kolachalama | 09 Jul 2024 | 00:51:16 | |
In this episode of Research Renaissance, Dr. Vijaya Kolachalama, associate professor at Boston University and a Toffler Scholar, discusses his pioneering work in developing software frameworks that assist neurologists in dementia screening. This engaging discussion delves into how Dr. Kolachalama's team is integrating artificial intelligence and machine learning to improve the diagnostic process in neurology. Key Points Discussed:
For those interested in the detailed workings of Dr. Kolachalama's research or wishing to participate in ongoing studies, visit the lab's website or reach out via email at vkola@bu.edu. This conversation is a must-listen for anyone interested in the intersection of technology, healthcare, and neurology. Stay connected with the Research Renaissance podcast by subscribing and visiting tofflertrust.org for more episodes and information on the Karen Toffler Charitable Trust. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Navigating Health Policy and Public Advocacy with Dr. Marci Nielsen | 02 Jul 2024 | 01:05:21 | |
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. Embark on a journey into the forefront of cutting-edge brain science as we feature insightful discussions with a diverse array of guests from early career researchers pioneering groundbreaking science to influential voices in investment communities, policymaking, and research institutions. Together, we delve into neurological diseases, their causes, treatments, and the quest for cures. In this episode, we are joined by Dr. Marci Nielsen, a prominent figure in healthcare policy and executive management. Dr. Nielsen shares her unique career journey from hard sciences to public health and health policy, highlighting her roles in academia, government, and advocacy. The discussion covers the differences between global and public health policy, the challenges within the U.S. health system, and the impact of COVID-19 on public health management. Dr. Nielsen also delves into the CVKey Project, a technological initiative to help communities safely reopen during the pandemic. The conversation extends to the future of public health, strategies for rebuilding public trust, and the importance of investment in science and research. Dr. Nielsen’s passion and optimism for the next generation's role in addressing healthcare challenges shine through, offering a hopeful outlook for the future. "From everyone who has been given much, much will be demanded. I feel like I've got an obligation to take what I know and help others know it too." -Dr. Marci Nielsen Thank you for joining us on this episode of Research Renaissance. Until next time, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Shedding Light on Alzheimer's with Sheila Griffith and Aaron Schulman | 27 Jun 2024 | 01:05:11 | |
In this episode of Research Renaissance, host Deborah Westphal delves into the crucial topic of Alzheimer's disease and the transformative efforts of the Alzheimer's Association. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| AI Meets Alzheimer's: A Journey with Dr. Andrew Holbrook | 25 Jun 2024 | 00:49:26 | |
In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Andrew Holbrook, an Assistant Professor of Biostatistics at UCLA and a 2023 Toffler Scholar. Dr. Holbrook shares his fascinating journey from studying ancient languages and teaching in China to pioneering research in biostatistics and Alzheimer's disease. Together, they delve into the intersection of artificial intelligence, advanced algorithms, and brain science, exploring how these tools are revolutionizing our understanding of neurological diseases. Key Topics Discussed: Dr. Holbrook's Unique Journey: From studying ancient Greek, Latin, and German literature to teaching in China and eventually finding his passion in biostatistics and AI. AI and Alzheimer's Research: How Dr. Holbrook uses AI and advanced algorithms to understand the brain and Alzheimer's disease better. The importance of cortical thickness measurements and their role in predicting Alzheimer's. Statistical Challenges and Innovations: The complexity of analyzing structured data with time and spatial dimensions, and the breakthroughs in AI that are making real-time brain analysis possible. The Role of Deep Learning: An explanation of deep learning and its critical role in accelerating data analysis, making it feasible to process complex brain imaging data quickly. Collaboration and Open Source in Research: The importance of interdisciplinary teams and the role of open source software in advancing scientific research. Personal Connection to Alzheimer's: Dr. Holbrook's motivation is driven by personal experiences and the broader impact of neurological diseases on families. Future of AI in Medicine: Predictions for the next 5-10 years, including the development of precision medicine tools and the use of functional brain data for early detection of dementia. "Deep learning is about approximating functions, and it allows us to do all sorts of interesting things in science and industry." - Dr. Andrew Holbrook Contact Information:aholbroo@g.ucla.edu Subscribe to Research Renaissance for more insightful discussions on cutting-edge brain science. Visit our website and feel free to reach out with your thoughts, suggestions, or inquiries about the Karen Toffler Charitable Trust. Thank you for joining us on this journey into the forefront of brain science. Together, we can advance our understanding of the brain and address its ailments. Until we meet again, onward and upward. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Non-Invasive Stimulation for Alzheimer's with Dr. Alexandra Touroutoglou | 18 Jun 2024 | 00:46:12 | |
In this insightful episode of Research Renaissance, Dr. Alexandra Touroutoglou shares her extensive work on brain imaging and non-invasive brain stimulation techniques to treat Alzheimer's disease and related dementias. Discover the cutting-edge technologies and methods being employed to understand and combat neurodegenerative diseases. Key Points Discussed:
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| From Lived Experience to Life-Changing Innovation: How Praxis Reimagines Spinal Cord Injury Solutions | 25 Nov 2025 | 00:59:53 | |
In this powerful episode of Research Renaissance, Arushi Raina and John Chernesky from the Praxis Spinal Cord Institute pull back the curtain on what it really takes to innovate in spinal cord injury—and why the future of neurological care depends on integrating technology, science, and most importantly, lived experience. Rather than treating individuals as patients or passive recipients of care, Praxis centers their entire innovation pipeline around those living with spinal cord injury (SCI), involving them from ideation through market launch. Arushi shares how shifting from product “for” to product “with” the SCI community has accelerated meaningful breakthroughs. John explains why he refuses the label “patient” and instead champions the term Plex – Persons with Lived Experience, a philosophy now driving clinical research, product development, and even investment strategies. From cutting-edge neuromodulation to low-cost wound gels saving lives, this conversation explores how innovation scales not by solving one condition in isolation—but by designing for complexity, translating solutions across adjacent neurological and aging populations, and creating sustainable pathways to market.
♿ Why integrating lived experience from day one leads to better innovation—and better outcomes 🔄 How a “test bed” approach in SCI is accelerating breakthroughs for MS, stroke, Parkinson’s, aging and more ⚙️ The surprising power of simple, scalable technologies—like a gel applied at the first sign of a pressure sore 🧩 Why coachability in entrepreneurs may matter more than capital in medtech success 🧠 Neuromodulation reversing effects of paralysis—and improving autonomic functions like temperature, bowel, and bladder control 💬 How real-time, direct feedback from SCI users saved startups from costly mistakes 📈 Why Praxis built a fund model that generates investor returns and channels profits back into the charity ❤️ What it means to rethink innovation around dignity, identity, and human mobility—not just mobility of limbs
“If technology can be used not only to make it acceptable, but to celebrate the different ways people walk and move through the world, that’s where innovation meets humanity.” — Arushi Raina Resources & Links 🌐 Praxis Spinal Cord Institute: PracticeInstitute.org
💌 Subscribe for more thought-provoking interviews To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| The Complex Web of Protein Misfolding and Neurodegeneration with Dr. Joseph Mazzulli | 11 Jun 2024 | 01:01:03 | |
In this intriguing episode, Dr. Joseph Mazzulli, a 2022 Toffler Scholar, dives deep into the mechanisms of protein misfolding and amyloid formation, and their links to cell death in neurodegenerative diseases such as Parkinson's and Alzheimer's. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Unveiling the Genetics of Brain and Body with Dr. Valerie Arboleda | 04 Jun 2024 | 01:03:18 | |
In this episode of Research Renaissance, presented by the Karen Toffler Charitable Trust, host Deborah Westphal explores the intricate world of genetic research with Dr. Valerie Arboleda. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Exploring Vascular Dysfunction in Alzheimer's with Dr. Silvia Fossati | 28 May 2024 | 00:59:44 | |
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal is joined by Dr. Silvia Fossati, Associate Professor of Neurosciences and Associate Director at the Alzheimer's Center at Temple University. Dr. Fossati, a 2021 Toffler Scholar, shares her insights on vascular dysfunction in the brain and its critical role in Alzheimer's disease and related conditions. Key Topics Covered: Academic Journey: Dr. Fossati's path from Tuscany to the forefront of Alzheimer's research in the United States, detailing her academic pursuits from Italy to NYU and finally to Temple University. Research Focus: The discussion delves into the significance of vascular dysfunction in Alzheimer's, emphasizing the amyloid deposits around brain vessels and their impact on brain health. Innovative Studies: Exploration of cerebral amyloid angiopathy (CAA) and its consequences on the brain's vascular system, including challenges with the blood-brain barrier and potential therapies. Blood-Brain Barrier Research: Current insights into the blood-brain barrier's role in Alzheimer's, the effects of new anti-amyloid therapies, and the importance of comprehensive vascular studies. Laboratory Priorities: Dr. Fossati highlights her lab's priorities, such as understanding mitochondrial dysfunction and exploring carbonic anhydrase inhibitors, which could lead to new treatments for Alzheimer's. Interdisciplinary Approaches: The necessity for collaborative research across various disciplines to enhance understanding and treatment of complex diseases like Alzheimer's. Dr. Fossati passionately explains the intricate relationship between the brain and vascular health, advocating for more focused research on how vascular issues contribute to Alzheimer's and other cognitive disorders. She also discusses the potential of existing drugs, like those for high altitude sickness, to treat cerebral conditions due to their effects on brain swelling and vascular integrity. For more insights and updates, subscribe to Research Renaissance on your favorite podcast platform and visit tofflertrust.org. Reach out to Dr. Silvia Fossati for collaborations or inquiries through her lab's website or directly via email at silvia.fossati@temple.edu. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||
| Parkinson's and Lewy Body Dementia - A Deep Dive into Cellular Mysteries with Dr. Matt Lavoie | 21 May 2024 | 01:03:28 | |
In this episode, Dr. Matt Lavoie discusses his pioneering work on Parkinson's disease, exploring the intricate genetic factors and potential pathologies related to Lewy body dementia. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. | |||